What oral antibiotic is recommended for a typical digital infection in an adult without known drug allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Antibiotic for Digital Infection

For a typical digital (finger) infection in an adult without drug allergies, prescribe cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily for 7-10 days.

Rationale and Evidence

Digital infections (such as paronychia, felon, or simple cellulitis of the finger) fall under the category of skin and soft tissue infections (SSTIs). The IDSA 2014 guidelines provide clear antibiotic recommendations for these infections 1.

First-Line Antibiotic Selection

For uncomplicated digital infections without systemic signs, the causative organisms are typically Staphylococcus aureus (methicillin-susceptible) and Streptococcus species. According to IDSA guidelines:

  • Cephalexin 500 mg four times daily is an excellent first-line choice 1

    • Provides reliable coverage against both staphylococci and streptococci
    • Well-tolerated with established safety profile
    • More convenient dosing than some alternatives
  • Dicloxacillin 500 mg four times daily is the oral agent of choice specifically for methicillin-susceptible staphylococcal infections in adults 1

    • Highly effective against MSSA
    • Less commonly used in modern practice but remains guideline-recommended

Alternative Options

If the patient has a non-immediate penicillin allergy (not anaphylaxis), cephalexin remains appropriate. For patients with immediate hypersensitivity reactions to beta-lactams:

  • Clindamycin 300-450 mg four times daily 1
    • Excellent staphylococcal and streptococcal coverage
    • Caution: potential for C. difficile infection with prolonged use
    • Consider local resistance patterns (inducible resistance possible)

When to Consider MRSA Coverage

Do NOT routinely cover for MRSA in simple digital infections unless:

  • Patient has failed initial antibiotic therapy
  • Presence of systemic inflammatory response syndrome (SIRS): fever >38°C or <36°C, heart rate >90, respiratory rate >24, WBC >12,000 or <4,000 1
  • Known MRSA colonization or previous MRSA infection
  • Severe immunosuppression

If MRSA coverage is needed, options include:

  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily 1
  • Doxycycline 100 mg twice daily 1

Treatment Duration

7-10 days is the standard duration for uncomplicated digital infections. Shorter courses risk treatment failure, while longer courses increase antibiotic resistance and adverse effects without additional benefit.

Critical Adjunctive Measures

Antibiotics alone are insufficient for many digital infections:

  • Incision and drainage is mandatory for purulent collections (abscess, felon)
  • Elevation of the affected hand reduces swelling and pain
  • Warm soaks 3-4 times daily promote drainage
  • Splinting may be needed for severe infections to reduce pain and promote healing

Common Pitfalls to Avoid

  1. Prescribing antibiotics without drainage: Purulent infections require source control; antibiotics are adjunctive
  2. Empiric MRSA coverage: Overuse drives resistance; reserve for specific indications
  3. Inadequate dosing: Ensure full therapeutic doses (cephalexin 500 mg QID, not 250 mg)
  4. Ignoring treatment failure: If no improvement in 48-72 hours, consider MRSA, inadequate drainage, or deeper infection (tenosynovitis, osteomyelitis)

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.